Vitexin

Bioss Antibodies

Vitexin [3681-93-4]

16

Research Use Only

>98%

alpha-Glucosidase inhibitor [3, 8]. Antioxidant [1, 3]. HIF-1 alpha inhibitor [2]. Anti-metastatic [2, 13]. Apoptosis inducer [4, 9, 13]. Tumor suppressor [4, 9]. Adipogenesis inhibitor [5]. Inhibits SIRT6 in vitro [6]. Inhibits polyubiquitin synthesis by the ubiquitin-conjugating enzyme E2-25K [7]. Cardioprotective [10]. Anti-inflammatory [11]. Shows analgesic effect by targeting TRPV1 channel activity [11]. Neuroprotective. Inhibits NMDA receptors [12].

-20°C

51202000